Anxiety Drugs Flashcards

1
Q

Drug classes to treat anxiety?

A
Benzodiazepines
Azapirones
Serotonin Specific Reuptake Inhibitors (SSRI)
Serotonin & NE Reuptake Inhibitors
Antihistamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA of BDZs?

A

BDZ’s bind to specific sites which are separate from but adjacent to the receptor for GABA. BDZ receptors are found in CNS & location parallels GABA neurons. Binding of BDZs enhances the affinity of GABA receptors, resulting in more frequent opening of adjacent Cl- channels resulting in hyper polarization and inhibition of neuronal firing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 2 BDZ receptors?

A

BZ1- assoc w/ sleep
BZ2- assoc w/ memory, motor, sensory & cognitive function (muscle relaxation, ataxia, emotional behavior, anxiolytic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

BDZ Pharmacokinetics

A

BDZ are lipid soluble and taken up rapidly in the brain and other perfused organs. They then get redistributed to tissue less well perfused. They do cross the placenta & get secreted into breast milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

BDZ Metabolism

A

undergo hepatic metabolism to water soluble compounds for elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Short Acting BDZ

A

Lasts 3-8 hours

Oxazepam- good for elderly & those w/ hepatic disease. Has no active metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Intermediate BDZ

A

Lasts 3-8 hours
Lorazepam- good for elderly & those with hepatic disease
Alprazolam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Long Acting BDZ

A

Lasts 1-3 days
Chlordiazepoxide
Diazepam
Clorazepate- prodrug, must be converted to active metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Adverse effects of BDZ

A
Drowsiness & confusion
Ataxia
Cognitive Impairment
Potentiate alcohol & other CNS depressants
Tolerance is common w/ BDZ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a BZD Antagonist?

A

FLUMAZENIL- binds to specific sites, where it competitively antagonizes the binding and allosteric effects of BDZ’s
Indications: suspected BDZ overdose, reverse sedative effects administered during anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Buspirone

A

Actions are mediated by serotonin receptors (5HT1a). 5HT1a are mostly somatodendritic auto receptor that are coupled to G proteins regulating k+ membrane channel. Increase opening- hyperpolarizes the neuron and decreases firing
Buspirone is a partial agonist
Has a slow onset (2 weeks)
No physical dependence/ withdrawal syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SSRI MOA?

A

Selectively inhibit the reuptake of serotonin at the transporter. By blocking neurotransmitter removal serotonin concentration increases in the synaptic cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SSRI Drugs

A
Paroxetine- social anxiety disorder
Sertaline- used in PTSD
Escitalopra
SSRI's don't have physical dependence and do not potentiate CNS depression of alcohol. 
SSRI's have a delayed onset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SSRI Adverse Reactions

A

CNS- insomnia, tremor
CV- palpitations, hypotension, vasodilation
GI- anorexia
GU- loss of libido, sexual dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SSRI Drug Interactions

A

MAOI’s can cause fatal reactions. If pt taking MAOI’s and switch to SSRI’s wait 14 days before starting. Get “serotonin syndrome”- hyperthermia, muscle rigidity, myoclonus, rapid changes in mental status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SNRI MOA

A

blocks serotonin & NE reuptake transporters

17
Q

What is Venlafaxine?

A

SNRI
Used to general anxiety disorder
Adverse: Similar to SSRI; can also cause hypertension
DO NOT abruptly discontinue- slowly titrate the pt off the drug

18
Q

Antihistamines MOA

A

Antagonist at H1 receptors located in hippocampus and cortex

19
Q

Antihistamine Agents

A
Piperazine derivative
Hydroxyzine HCL
Hydroxyzine Pamoate
Used to General Anxiety Disorder
Adverse: Sedation. Do not combine w/ alcohol
20
Q

Drugs to treat Insomnia

A

Benzodiazepines

Miscellaneous

21
Q

Short Acting Hypnotic BDZs

A

last 3-8 hours
Midazolam- used as preanesthetic and intraoperative medication. Given as an oral syrup
Triazolam-Used to induce sleep in patients w/ recurring insomnia
tolerance develops in a few days
withdrawal results in rebound insomnia

22
Q

Intermediate BDZ’s

A

Lasts 10-20 hours
Temazepam
Estazolam- useful in pt who experience frequent wakening, peak sedative effect occurs 2-3 hours after oral dose

23
Q

Long Acting BDZ’s

A

Lasts 1-3 days
Quazepam
Flurazepam- significantly reduces sleep-induction time, decreases number of wakening, increase duration of sleep

24
Q

Contraindication of BDZ

A

Patient’s with obstructive sleep apnea b/c they decrease muscular tone in upper airway and exaggerate the impact of the episodes of apnea
Do not combine w/ alcohol

25
Q

Zolpidem

A

MOA: Binds to BZ1 receptor subtype at GABA -Cl channel receptor complex
Advantage- does not effect different stages of sleep like BDZs, minimal rebound insomnia, little or no tolerance
Releases 5 or 10 mg immediately and then the rest is released 3 hours later to maintain sleep. effect lasts 7-8 hours

26
Q

Zaleplon

A

MOA- binds to BZ1 receptor subtype at the GABA-Cl channel receptor complex
Little or no tolerance occurs

27
Q

Eszopiclone

A

MOA: binds to BZ1 receptor subtype at GABA-Cl channel receptor complex
Exhibits minimal rebound insomnia- helps to sleep longer
Little/ no tolerance approved for long term

28
Q

Ramelteon

A

Melatonin receptor agonist for the treatment of insomnia. For pt w/ difficultly w/ sleep onset
affinity for Melatonin MT1 &MT2 (promotion of sleep)
no affinity for GABA-A-BDZ= no anxilyic, muscle relaxant, amnesic effects

29
Q

Suvorexant

A

MOA- blocks the binding of wake-promoting neuropeptides orexin A and orexin B to receptor OX1R and OX2R.